IDEXX Laboratories, Inc. (NASDAQ:IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market ...
Barclays raised the firm’s price target on Idexx Laboratories (IDXX) to $520 from $481 and keeps an Overweight rating on the shares. The company reported a Q4 beat and “healthy” 2025 revenue guidance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback